If you have diabetes and bladder cancer, you've come to the right place for information. You're no doubt troubled by the Food and Drug Administration's warning in June 2011 that long-term use of Actos, or pioglitazone, to control blood sugar has been associated with an increased bladder cancer risk.
This news has prompted a great number of Actos lawsuits filed on behalf of patients in the United States seeking to recover damages from Takeda Pharmaceuticals, the maker of the drug.
Actos Lawsuits Claim Takeda Withheld Bladder Cancer Information
Bloomberg Business week reported March 15, 2012, that Takeda Pharmaceuticals may face 10,000 claims in U.S. Federal Court by patients who believe their bladder cancer was linked to their diabetes medicines. Their Actos lawsuits accuse Takeda of withholding information about the bladder cancer risk and claim the company didn't adequately notify patients about it.
In December, these Actos lawsuits were consolidated before U.S District Judge Rebecca Doherty in Lafayette, La., and she has appointed 19 lawyers to manage the litigation. The first hearings are scheduled for March 22.
ActosLawsuit.com was created as a comprehensive, authoritative resource for people like you who have discovered they have bladder cancer.
Have Your Claim Evaluated
Please read on to educate yourself about this important problem, and if at any time you'd like your own case evaluated by a qualified Actos attorney experienced in defective-drug litigation, simply request a free case evaluation. You'll be contacted within 24 hours.
In addition, please take advantage of all the free information available on this site about Actos, bladder cancer and its treatment. We've created it just for you, so you can take charge of your health right away.